Jens Grueger, PhD, is a distinguished figure in the pharmaceutical industry, renowned for his extensive expertise in global market access, pricing, and health economics. Over his 40-year career, he has held pivotal leadership roles, including Senior Vice President and Head of Global Access at Roche (2011–2019), Vice President and Head of Global Market Access Primary Care at Pfizer (2009–2011), and Head of Global Pricing & Health Economics at Novartis (1999–2009). In these capacities, Dr. Grueger spearheaded initiatives to develop and implement value-based pricing models, such as risk-sharing and performance-based pricing, aimed at accelerating patient access to innovative medicines. Transitioning to consultancy, he joined the Boston Consulting Group in 2019 as Director and Partner, serving as the senior expert for pricing and market access in the life sciences. Beyond his corporate endeavors, Dr. Grueger has contributed significantly to academia and professional societies. He is an Affiliate Professor of Health Economics at the University of Washington’s CHOICE Institute and served as President of ISPOR, the leading professional society for health economics and outcomes research, during the 2020–2021 term.
Dr. Grueger’s extensive experience in navigating diverse international healthcare landscapes will be instrumental in extending to international markets the same level of strategic insight, reputation, and credibility that Curta has built in the United States. Dr. Grueger will work closely with the Curta Global Market Access team, led by Dr. Sean Sullivan, to help life sciences companies ensure that their products reach the patients who will benefit from them. In a time of rapid change in the healthcare ecosystem, Dr. Grueger’s years of experience and experience will further strengthen Curta’s commitment to delivering innovative, evidence-based solutions that address the complex challenges of global healthcare markets.